Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Modified Hoehn and Yahr Staging Scale (H&Y)

Sep 11, 2023/Test & Measure

Used to stage Parkinson disease by level of severity related to impairments, especially postural instability, and activity limitations.

10-Meter Walk Test (10MWT) for Parkinson Disease (PD)

Apr 29, 2013/Test & Measure

10-Meter Walk Test (10MWT) (also known as "Gait Speed") for Parkinson Disease

Dynamic Gait Index (DGI) for Vestibular Disorders

May 14, 2013/Test & Measure

Dynamic Gait Index (DGI) for Vestibular Disorders

APTA Academy of Orthopaedic Physical Therapy and American Academy of Sports Physical Therapy: Heel Pain––Plantar Fasciitis: Revision 2023 (CPG+)

Dec 1, 2023/CPG

This updated guideline from APTA's American Academy of Orthopaedic Physical Therapy and American Academy of Sports Physical Therapy makes recommendation for the physical therapist management of non-arthritic heel pain for individuals 16 and older.

DoD Moves to Include PTAs in TRICARE

Dec 20, 2018/News

Nearly a year after being signed into law, a proposed rule to include PTAs as authorized providers under TRICARE has been issued by the US Department of Defense.

Oncology Section Introduces New Guideline on Diagnosis of Upper Quadrant Lymphedema in Patients With Cancer

Jun 29, 2017/News

Few CPGs exist to help clinicians diagnose upper quadrant lymphedema secondary to cancer. The APTA Oncology Section set out to change that with the publication of a new guideline in PTJ.

Anterior Cruciate Ligament (ACL) Injury

May 22, 2024/Clinical Summary

Physical therapy interventions can increase the chances that the patient will return to preinjury activity levels and prevent a recurrence.

Geriatric Depression Scale (GDS)

Jun 6, 2019/Test & Measure

Measures depression and suicidal ideation in elderly people.

Rate Your Plate (RYP)

Sep 7, 2022/Test & Measure

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1